Search results

Showing 1 – 14 of 14 results.

Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2002 (ICPSR 3815)

Released/updated on: 2006-03-30

Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Sacramento, Seattle, California, Washington, District of Columbia, Pennsylvania, Tulsa, Laredo, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia

Time period: 2002-01-01--2002-12-31

The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2002 at four separate times (quarterly) during the year in 36 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. Data from arrestees in juvenile detention facilities (Part 3) continued to use the juvenile instrument from previous years, extending back through the DRUG USE FORECASTING series (ICPSR 9477). The ADAM program in 2002 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) weights. The juvenile file contains demographic variables and arrestee's self-reported past and continued use of 15 drugs, as well as other drug-related behaviors.

Curated

Arrestee Drug Abuse Monitoring (ADAM) Program in the United States, 2003 (ICPSR 4020)

Released/updated on: 2006-03-30

Geographic coverage: North Carolina, Oklahoma City, Charlotte, Indiana, Tucson, Albuquerque, Spokane, Utah, San Jose, New York City, San Diego, Arizona, Las Vegas, Boston, Sacramento, Seattle, California, Florida, Pennsylvania, Tulsa, Iowa, Illinois, Texas, Portland (Oregon), Georgia, Tampa, Indianapolis, Oregon, United States, Oklahoma, Rio Arriba, Alabama, Cleveland, Washington, Nebraska, Albany (New York), Omaha, Minneapolis, Woodbury, Atlanta, Massachusetts, Colorado, Honolulu, New Orleans, Alaska, Phoenix, Denver, Salt Lake City, Dallas, Nevada, Des Moines, District of Columbia, San Antonio, Chicago, Hawaii, Minnesota, New York (state), Birmingham, Miami, New Mexico, Louisiana, Anchorage, Ohio, Los Angeles, Philadelphia, Houston

Time period: 2003-01-01--2003-12-31

The goal of the Arrestee Drug Abuse Monitoring (ADAM) Program is to determine the extent and correlates of illicit drug use in the population of booked arrestees in local areas. Data were collected in 2003 up to four separate times (quarterly) during the year in 39 metropolitan areas in the United States. The ADAM program adopted a new instrument in 2000 in adult booking facilities for male (Part 1) and female (Part 2) arrestees. The ADAM program in 2003 also continued the use of probability-based sampling for male arrestees in adult facilities, which was initiated in 2000. Therefore, the male adult sample includes weights, generated through post-sampling stratification of the data. For the adult male and female files, variables fell into one of eight categories: (1) demographic data on each arrestee, (2) ADAM facesheet (records-based) data, (3) data on disposition of the case, including accession to a verbal consent script, (4) calendar of admissions to substance abuse and mental health treatment programs, (5) data on alcohol and drug use, abuse, and dependence, (6) drug acquisition data covering the five most commonly used illicit drugs, (7) urine test results, and (8) for males, weights.

Curated

Arrestee Drug Abuse Monitoring II in the United States, 2012 (Restricted Use) (ICPSR 34821)

Released/updated on: 2013-08-29

Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)

Time period: 2012-04-30--2012-07-29

The Arrestee Drug Abuse Monitoring II, 2012 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2012 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2012 survey represents the sixth year of ADAM II and includes data from 1,938 interviews and 1,736 urine tests that were conducted at the five ADAM II sites over a 21-day period, between April 30 and July 29, 2012. The samples from these sites were weighted to represent over 14,000 arrests of adult males in the five counties. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.

Curated

Arrestee Drug Abuse Monitoring II in the United States, 2013 (Restricted Use) (ICPSR 35169)

Released/updated on: 2014-08-01

Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)

Time period: 2013-05-05--2013-07-28

The Arrestee Drug Abuse Monitoring II, 2013 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2013 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2013 survey represents the seventh year of ADAM II and includes data from 1,900 interviews and 1,681 urine tests that were conducted at the five ADAM II sites over a 21-day period, between May 5, 2013 and July 28, 2013. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, citizenship, marital status, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2007 (ICPSR 25821)

Released/updated on: 2010-01-28

Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis

Time period: 2007-04-01--2007-09-01

The Arrestee Drug Abuse Monitoring (ADAM) II program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, the ONDCP and Abt Associates have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. A total of 8,296 arrestees were interviewed during the second and third quarters of 2007. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. The Arrestee Drug Abuse Monitoring (ADAM) II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2008 (ICPSR 27221)

Released/updated on: 2010-03-31

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc. have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collects data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Data collection has been conducted across two back-to-back quarters in each of 10 counties from a county-based representative sample of 250 male arrestees per quarter for a total of 500 arrestees annually per site or a total of 5,000 arrestees across sites annually. A total of 7,717 arrestees were interviewed during the second and third quarters of 2008. Collection occurs in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2007 and ending March 31, 2008. Additional data collection periods were optioned by ONDCP, and subsequent cycles of back-to-back data collection (not yet available) began April 1, 2008. Participation is voluntary and confidential, and the procedures include a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)

Released/updated on: 2011-02-24

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)

Released/updated on: 2011-11-04

The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.

Curated

Simple Crosstabs

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] (ICPSR 36575)

Released/updated on: 2017-08-08

Geographic coverage: North Carolina, Milwaukee, Indiana, Ocean (New Jersey), Fort Worth, Cincinnati, Austin, Monmouth (New Jersey), Utah, San Jose, Rock Hill, Gastonia, San Diego, Columbus (Ohio), Syracuse, Springfield (Massachusetts), North Little Rock (Arkansas), Arizona, Las Vegas, Arlington, Springfield (Ohio), Boston, San Bernardino, Providence, Seattle, Kentucky, St. Petersburg, Bethlehem, Niagara Falls (New York), Nashville, California, Florida, Delaware, Hunterdon (New Jersey), Boca Raton (Florida), Troy, Knoxville, Mississippi, Fresno, New Haven, Sarasota, Illinois, Newark, Georgia, Little Rock, Virginia, Maryland, Norfolk, Virginia Beach, Suffolk County (New York), United States, Oklahoma, Grand Rapids, Louisville, Waukesha (Wisconsin), Arkansas, Washington, South Carolina, Albany (New York), Wichita, Mesa (Arizona), Carlisle (Pennsylvania), Fall River, Massachusetts, Missouri, Winston-Salem, Holland (Michigan), New Orleans, Scranton, Denver, Salt Lake City, Harrisburg, Dallas, St. Louis, Nevada, Schenectady, Allentown, Raleigh, San Antonio, Muskegon, St. Paul, Clearwater, Hawaii, Rochester (New York), Passaic, Ventura (California), Birmingham, Michigan, Lebanon, Baltimore, New Mexico, Orlando, Louisiana, Toledo, Middlesex (New Jersey), Philadelphia, Riverside, Oklahoma City, Akron, Greensboro, Detroit, Charlotte, High Point, Tucson, Albuquerque, Everett, Oakland, Bakersfield, New York City, Somerset (New Jersey), Petersburg, Memphis, Ogden, Jacksonville, Buffalo, Pittsburgh, Nassau (New York), Orange County (California), Sacramento, El Paso, Greenville, Kansas, Meriden, Pennsylvania, Tulsa, Chapel Hill (North Carolina), West Palm Beach, Iowa, Texas, Lorain, Portland (Oregon), Hazleton, Tampa, Durham, San Marcos (Texas), Indianapolis, Richmond, Oregon, Warwick, Bergen (New Jersey), Newport News, Ann Arbor, Alabama, Cleveland, Dayton, Nebraska, Omaha, Warren, West Virginia, Elyria, Tacoma, Minneapolis, Youngstown, Atlanta, Honolulu, Phoenix, Bradenton, Wilmington (Delaware), Gary, District of Columbia, Rhode Island, Vancouver (Washington), Lodi (California), Chicago, Fort Lauderdale, Wilkes-Barre, Minnesota, Kansas City (Missouri), Bellevue, New York (state), Anderson, New Jersey, Miami, San Francisco, Charleston (South Carolina), Jersey City, Long Beach, Spartanburg (South Carolina), New Hampshire, Easton, Ohio, Los Angeles, Hartford, Stockton, Houston

Time period: 1990-01-01--2013-01-01

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] study (CVAR) was a research study of why large United States Metropolitan Statistical Areas (MSAs) vary over time in their vulnerability to HIV/AIDS among drug users and in MSA responses to HIV/AIDS. This collection contains estimates of HIV prevalence among people who injected drugs (PWID) and among sub-populations of PWID. This collection is comprised of ten datasets with differing amounts of variables and provides trend data that describe the following:

Epidemiologic outcomes including population prevalence of PWIDs and Non-injecting drug users (NIDUs), and particularly their prevalence among youth; and, among PWIDs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality.
Implementation of evidence-based drug-related interventions including drug abuse treatment, syringe exchange, HIV counseling and testing.
Implementation of non-evidence-based drug-related interventions including incarceration and arrests of drug users.

The collection contains data on the MSA sub-populations including Black, Hispanic, White and "other" race categories. In addition, some statistics are presented in age range categories such as ages 15-29, 30-64 and 15-64.

Curated

HIV Transmission Network Metastudy Project: An Archive of Data From Eight Network Studies, 1988--2001 (ICPSR 22140)

Released/updated on: 2011-08-09

Geographic coverage: Manitoba, United States, Brooklyn, Flagstaff, New York (state), Global, Canada, Baltimore, Atlanta, Texas, Colorado, Georgia, Maryland, Colorado Springs, Arizona, Houston

Time period: 1988-01-01--2001-01-01

The purpose of this project was to establish a collection of datasets that could be used (1) to analyze the influence of partnership networks on the transmission of sexually transmitted and blood-borne infections, and (2) to examine the influence of study design on estimation of network properties and impacts. Eight studies contributed datasets to the collection.

They include:

Colorado Springs Project 90, 1988-1992
Bushwick [Brooklyn, NY] Social Factors and HIV Risk (SFHR) Study, 1991-1993
Atlanta Urban Networks Project, 1996-1999
Flagstaff Rural Network Study, 1996-1998
Atlanta Antiretroviral Adherence Study, 1998-2001
Houston Risk Networks Study, 1997-1998
Baltimore SHIELD (Self-Help in Eliminating Life-Threatening Diseases), 1997-1999
Manitoba Chlamydia Study, 1997-1998

Each study contains information on sexual, needle sharing, and/or social networks. Each dataset was harmonized to permit comparative analysis. Almost all of the studies were research projects funded by federal agency sources (e.g., United States Centers for Disease Control and the National Institutes of Health); one was funded by Canadian sources. These studies, all closed for further enrollment, provide a range of designs and study types as well as a range of transmitted diseases. This allows researchers to investigate the relative effect of personal behavior and network connections on the dynamics of disease transmission, and to explore the impact of sampling design on estimation of network properties. Respondents were asked questions about different test results such as HIV, chlamydia, syphilis and hepatitis. Demographic variables include race, ethnicity, marital status, age, and gender.

Curated

Monitoring Drug Epidemics and the Markets That Sustain Them, Arrestee Drug Abuse Monitoring (ADAM) and ADAM II Data, 2000-2003 and 2007-2010 (ICPSR 33201)

Released/updated on: 2012-12-13

Time period: 2000-01-01--2003-01-01, 2007-01-01--2010-01-01

This study examined trends in the use of five widely abused drugs among arrestees at 10 geographically diverse locations from 2000 to 2010: Atlanta, Charlotte, Chicago, Denver, Indianapolis, Manhattan, Minneapolis, Portland Oregon, Sacramento, and Washington DC. The data came from the Arrestee Drug Abuse Monitoring Program reintroduced in 2007 (ADAM II) and its predecessor the ADAM program. ADAM data included urinalysis results that provided an objective measure of recent drug use, provided location specific estimates over time, and provided sample weights that yielded unbiased estimates for each location. The ADAM data were analyzed according to a drug epidemics framework, which has been previously employed to understand the decline of the crack epidemic, the growth of marijuana use in the 1990s, and the persistence of heroin use. Similar to other diffusion of innovation processes, drug epidemics tend to follow a natural course passing through four distinct phases: incubation, expansion, plateau, and decline. The study also searched for changes in drug markets over the course of a drug epidemic.

Curated

National Supported Work Evaluation Study, 1975-1979: Public Use Files (ICPSR 7865)

Released/updated on: 2009-02-02

Geographic coverage: United States, Chicago, California, Oakland, New York (state), New Jersey, Pennsylvania, New York City, Atlanta, Illinois, Connecticut, Hartford, Georgia, Wisconsin, Philadelphia

Time period: 1975-01-01--1979-01-01

This study is an evaluation of the National Supported Work Demonstration project, a transitional, subsidized work experience program for four target groups of people with longstanding employment problems: ex-offenders, former drug addicts, women who were long-term recipients of welfare benefits, and school dropouts, many with criminal records. The program provided up to 12-18 months of employment to about 10,000 individuals at 15 locations across the country for four years. In ten of these sites -- Atlanta, Chicago, Hartford, Jersey City, Newark, New York, Philadelphia, Oakland, San Francisco, and Wisconsin, 6,600 eligible applicants were randomly assigned either to experimental groups (offered a job in supported work) or to control groups, and an evaluation was conducted on the effects of the Supported Work Program. At the time of enrollment, each respondent was given a retrospective baseline interview, generally covering the previous two years, followed by up to four follow-up interviews scheduled at nine-month intervals. Two public use files were originally distributed for this data collection: Supported Work Employment and Earnings File, and Supported Work Deviant Behavior File. Each file contained data for up to five interviews, a cross-document dataset and an Aid to Families with Dependent Children (AFDC) recipients follow-up. The Employment and Earnings File contains data from all interview modules except the drug and crime sections, and the Deviant Behavior File contains all variables on the Employment and Earnings File as well as additional information on drugs and crime. Aid to Families with Dependent Children (AFDC) recipients were further asked about children in school and welfare participation, while all non-AFDC respondents were questioned about any extralegal activities. Demographic items specify age, sex, race, marital status, education, number of children, employment history, job search, job training, mobility, household income, welfare assistance, housing, military discharge status, and drug use. Each respondent has up to six logical, fixed-length records, with each record corresponding to a completed interview (up to five) and one additional short "cross-document" record. A User's Guide describing the collection and its components is available and should be read before the collection or any part of it is ordered.

Curated

Restricted

Planning for SUCCESS (Sustained, Unbroken Connections to Care, Entry Services, and Suppression): Phase II of a Project to Improve the Connection to Community Care for HIV-Infected Persons Leaving Jail in Atlanta, 2014-2015 (ICPSR 39799)

Released/updated on: 2026-06-30

Geographic coverage: United States, Atlanta, Georgia

Time period: 2014-08-01--2015-02-01

This feasibility study tested the logistics and acceptance of the intervention and its evaluation tools against "usual care" conditions in preparation for a future randomized controlled trial. Specific aims included:

Demonstrating that recruitment and delivery of the intervention are feasible.
Demonstrating that enrolled releasees will link to HIV care by 3 months post release. A successful linkage to HIV medical care was defined as a confirmed visit to a clinic post release, validated by a recorded HIV viral load and CD4 count in the clinic's medical records.
Documenting retention in care, defined as a minimum of 2 HIV clinical visits occurring within 12 months post release, with at least 2 clinical visits spaced a minimum of 3 months apart. Related retention outcome measures included proportion with viral load suppression and, as needed, attendance at substance abuse rehabilitation, and mental health treatment.

Data was collected at baseline, and at 3 and 12 months post-release. The 1st and 2nd sessions occurred in jail and 4 post-release sessions in the community.

Curated

Restricted

Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users, Florida and Georgia, 2013-2015 (ICPSR 39792)

Released/updated on: 2026-04-22

Geographic coverage: United States, Atlanta, Georgia, Florida, Miami

Time period: 2013-01-01--2015-04-30

This Fast Release study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project, which involved over twenty studies in the fields of HIV and drug abuse. All files in the compressed zip package are released as deposited by the PI and were not further processed.

This study evaluated the efficacy of an integrated "Retention Clinic" in achieving virologic suppression among HIV-infected cocaine users.